CDHA CAAR

February 7, 2018

CAAR – Lancet Oncology Article Abstracts – February 7, 2018

Filed under: Reports and Articles — Tags: , — admin @ 3:15 pm

A. “Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study,” by Courtney D. DiNardo, Keith W. Pratz, Anthony Letai, Brian A. Jonas, Andrew H. Wei, Michael Thirman, Martha Arellano, Mark G. Frattini, Hagop Kantarjian, Relja Popovic, Brenda Chyla, Tu Xu, Martin Dunbar, Suresh K. Agarwal, Rod Humerickhouse, Mack Mabry, Jalaja Potluri, Marina Konopleva, and Daniel A. Pollyea (Vol. 19, No. 2, February 2018, p. 216-228).

www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30010-X/abstract

B. “Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study,” by Hagop Kantarjian, Farhad Ravandi, Nicholas J. Short, Xuelin Huang, Nitin Jain, Koji Sasaki, Naval Daver, Naveen Pemmaraju, Joseph D. Khoury, Jeffrey Jorgensen, Yesid Alvarado, Marina Konopleva, Guillermo Garcia-Manero, Tapan Kadia, Musa Yilmaz, Gautam Bortakhur, Jan Burger, Steven Kornblau, William Wierda, Courtney DiNardo, Alessandra Ferrajoli, Jovitta Jacob, Rebecca Garris, Susan O’Brien, and Elias Jabbour (Vol. 19, No. 2, February 2018, p. 240-248).

www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30011-1/abstract

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.